Could melatonin have a potential adjuvant role in the treatment of the lasting anosmia associated with COVID‐19? A review
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Developmental Neuroscience"
DOI: 10.1002/jdn.10208
Abstract: Anosmia, the loss of the sense of smell, is usually associated with rhinopathies and has been reported as a common symptom of COVID‐19. There is no specific drug to treat this condition, although some evidence… read more here.
Keywords: could melatonin; role treatment; treatment lasting; adjuvant role ... See more keywords